Not yet recruiting
Tick-borne viral encephalitis
Not yet recruitingTesting Remdesivir in Hospitalized Adult Patients with Tick-Borne Encephalitis to Measure Effects on Brain Cell Damage
Registered drug
Testing Remdesivir in Hospitalized Adult Patients with Tick-Borne Encephalitis to Measure Effects on Brain Cell Damage
Registered drug
- Disease:Tick-borne viral encephalitis
- Substances:Mannitol
Countries:
Sweden
Sweden- Participants:18–64 years · 65+ years
- Substances:Mannitol
- Sponsor:Region Stockholm – SLSO